Conference Presentation Details - Table of Contents
10th International Lung Cancer Congress
Release Date: June 24, 2009| Jun 17-20, 2009, Kohala Coast, HI
Table of Contents
Early-Stage NSCLC
Neoadjuvant Chemotherapy
Joan H. Schiller
Adjuvant Therapy for NSCLC
Heather Wakelee
Debate: Stage vs. Molecular Markers in Stage IIA NSCLC
Markers
Giorgio Scagliotti
Debate: Stage vs. Molecular Markers in Stage IIA NSCLC
Stage
Kemp H. Kernstine
Debate: Radiation Therapy vs. Surgery in Early-Stage NSCLC
Radiation
Walter Curran, Jr
Debate: Radiation Therapy vs. Surgery in Early-Stage NSCLC
Surgery
David M. Jablons
When Are Sublobar Resections Appropriate?
Stephen Swisher
Panel Discussion: IASLC Staging
Project Harvey I. Pass, Paul Baas, David Gandara, Hak Choy
Keynote Lecture: BATTLE Program for Personalized Medicine
Roy Herbst
Angiogenesis Inhibition
Overview of Angiogenesis Inhibition
Roy Herbst
Combination Regimens to Inhibit Multiple Signaling Pathways
Glenwood Goss
Managing Toxicities of Antiangiogenic Agents: Practical Advice for the Clinic
Karen Kelly
Poster Discussion 1
H. Jack West
Workshop 1: The Next Generation of Targeted Agents in Lung Cancer (CME-Designated Workshop)
Overview
Paul A. Bunn, Jr
P13K/Akt Inhibitors
Roy Herbst
Apoptosis Inducers-Extrinsic
Karen Kelly
Apoptosis Inducers-Intrinsic
Primo N. Lara, Jr
FGF Inhibitors
Philip C. Mack
c-Met Inhibitors
Román Pérez-Soler
Hedgehog Inhibitors
David Gandara
Hsp90 Inhibitors
H. Jack West
EGFR Inhibitors in NSCLC
Population-Specific Implications of Anti-EGFR Agents
Paul A. Bunn, Jr
Overcoming Resistance to EFGR TKIs; Second-Generation TKIs
Heather Wakelee
Update on EGFR Antibodies in NSCLC
Román Pérez-Soler
Second Annual Addario Foundation Keynote Lecture: Mesothelioma
Harvey I. Pass
Multi-Targeted Agents
What’s New with Multikinase Inhibitors
Roy Herbst
Update on HDAC Inhibitors
Primo N. Lara, Jr
Personalized Medicine
Overview of Personalized Medicine
Paul A. Bunn, Jr
Biomarkers for Personalized Lung Cancer Therapy
Fred Hirsch
Role of Pathology/Molecular Diagnostics
Ignacio Wistuba
Supportive Care
Poster Discussion 2
Randeep Sangha, MD
Current and Future Management Strategies for Metastatic Bone Disease
Corey Langer
Workshop 2: Multidisciplinary Tumor Board (CME-Designated Workshop)
Surgery-Oriented Case
Harvey I. Pass
Early Stage with Poor Pulmonary Function
Water Curran, Jr
PCI for Stage III NSCLC
Water Curran, Jr
Optimizing Combined Modality Therapy for Lung Cancer
Chemoradiation Therapy for Stage III NSCLC: State-of-the-Art
A. William Blackstock
Introducing New Agents Into Combined Modality Therapy for NSCLC
Martin Edelman
Surgical Approaches in Locally Advanced NSCLC
Stephen Swisher
Innovative Approaches to Radiation Therapy, Including SBRT, IMRT, and Proton Beam Therapy
Hak Choy
Current Approaches to the Treatment of LD-SCLC
Walter Curran, Jr
Treatment of Advanced Lung Cancer
Lung Cancer Vaccines
David M. Jablons
Novel Cytotoxics in Metastatic NSCLC
Martin Edelman
Approaches to the Second-line Treatment of Metastatic NSCLC
Román Pérez-Soler
Optimal Application of Antifolates in NSCLC
David Gandara
Maintenance Therapy for NSCLC
Karen Kelly
Treatment of ED-SCLC
Primo N. Lara, Jr
IGF-1R Inhibitors
Randeep Sangha
Cooperative Group Update
Japan
Nagahiro Saijo
Europe
Paul Baas
SWOG
David Gandara
RTOG
Hak Choy
NCIC
Glenwood Goss
NCCTG
Alex Adjei
ECOG
Joan H. Schiller
CALGB
Martin Edelman
ACOSOG
Kemp H. Kernstine
Instructions for Participation
To view the streaming Flash Video lectures, click the "View Flash Presentation" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>
To download Podcast-ready movies, click "Download Video Podcast," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>
You will be asked to login
or create an account.